Effects of low-dose chronic diltiazem treatment on hemodynamic changes in spontaneously hypertensive rats. 1988

K Watanabe, and T Nishio, and C Mori, and M Kihara, and R Horie, and Y Yamori
Department of Pediatrics, Shimane Medical University, Izumo, Japan.

The effects of long-term diltiazem treatment on hemodynamic and cardiovascular characteristics were investigated in young spontaneously hypertensive rats (SHR), Wistar-Kyoto rats (WKY) and their respective untreated controls. The drug was administered to treated rats over a period of 24 weeks. Body weight, left ventricular weight, mean arterial pressure (MAP), heart rate, max dp/dt or maximum velocity of the contractile element (Vmax) were not significantly different in diltiazem-treated SHR and untreated SHR. In diltiazem-treated SHR, cardiac index (CI) and stroke volume index (SI) were significantly increased and total peripheral resistance and the index of left ventricular compliance (delta P/delta V) were significantly decreased compared with untreated SHR. Left ventricular pumping ability in treated SHR was higher than that in untreated SHR, despite the low dose of diltiazem given. However, there was no significant difference between treated and untreated WKY. Long-term diltiazem treatment did not affect left ventricular function or biochemical properties in SHR and WKY. These data suggest that long-term diltiazem treatment improves pump function in SHR without changing blood pressure.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D004110 Diltiazem A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of CALCIUM ion on membrane functions. Aldizem,CRD-401,Cardil,Cardizem,Dilacor,Dilacor XR,Dilren,Diltiazem Hydrochloride,Diltiazem Malate,Dilzem,Tiazac,CRD 401,CRD401
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

K Watanabe, and T Nishio, and C Mori, and M Kihara, and R Horie, and Y Yamori
January 1985, Clinical and experimental hypertension. Part A, Theory and practice,
K Watanabe, and T Nishio, and C Mori, and M Kihara, and R Horie, and Y Yamori
January 1984, Hypertension (Dallas, Tex. : 1979),
K Watanabe, and T Nishio, and C Mori, and M Kihara, and R Horie, and Y Yamori
May 1975, Archives internationales de pharmacodynamie et de therapie,
K Watanabe, and T Nishio, and C Mori, and M Kihara, and R Horie, and Y Yamori
November 1980, Atherosclerosis,
K Watanabe, and T Nishio, and C Mori, and M Kihara, and R Horie, and Y Yamori
September 2002, Planta medica,
K Watanabe, and T Nishio, and C Mori, and M Kihara, and R Horie, and Y Yamori
January 1985, Hypertension (Dallas, Tex. : 1979),
K Watanabe, and T Nishio, and C Mori, and M Kihara, and R Horie, and Y Yamori
January 1993, Clinical and experimental hypertension (New York, N.Y. : 1993),
K Watanabe, and T Nishio, and C Mori, and M Kihara, and R Horie, and Y Yamori
January 2010, Biological & pharmaceutical bulletin,
K Watanabe, and T Nishio, and C Mori, and M Kihara, and R Horie, and Y Yamori
February 1992, Cardiovascular drugs and therapy,
K Watanabe, and T Nishio, and C Mori, and M Kihara, and R Horie, and Y Yamori
October 1988, The American journal of cardiology,
Copied contents to your clipboard!